ArticleSignal transduction and targeted therapy2022

SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2.

Leyun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.